发明名称 GENE EDITING FOR HIV GENE THERAPY
摘要 The present disclosure is in the field of genome engineering, particularly targeted integration of anti-HIV transgenes into the genome of a cell for the treatment and/or prevention of HIV.
申请公布号 US2016022737(A1) 申请公布日期 2016.01.28
申请号 US201514807595 申请日期 2015.07.23
申请人 Sangamo BioSciences, Inc. ;University of Southern California 发明人 Gregory Philip D.;Wang Jianbin;Cannon Paula M.
分类号 A61K35/28;C12N15/85 主分类号 A61K35/28
代理机构 代理人
主权项 1. A method of generating a cell that will not sustain HIV infection, the method comprising genetically modifying the cell such that: (i) an endogenous restriction factor is modified to increase its activity against HIV; (ii) an endogenous viral host factor gene is modified to decrease its ability to support HIV infection; or (iii) an exogenous transgene encoding a Trim5α-Cyp fusion protein is inserted into an endogenous safe harbor locus wherein the cell will not sustain HIV infection.
地址 Richmond CA US